Transwell assays, immunofluorescence (IF) staining, Nile Rad staining, and measurements of triglyceride (TG) and total cholesterol (TC) levels demonstrated that SREBP1 silencing inhibits epithelial-mesenchymal transition (EMT) and lipid synthesis in ovarian cancer cells. Here, SREBF1 is linked to ovarian cancer.